Position in RLAY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,599,785
-$3,102,525 QoQ
Shares Held
192,399
-71.4% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#85
of 256 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. RLAY ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in RLAY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,599,785 | 192,399 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,702,310 | 673,599 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,481,225 | 647,899 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,340,634 | 1,023,110 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,218,406 | 1,508,210 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,963,408 | 2,276,110 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,382,662 | 1,549,190 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,751,352 | 671,095 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,926,921 | 909,037 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,334,560 | 763,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,563,937 | 323,700 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,216,927 | 144,700 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $1,957,525 | 118,854 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $908,352 | 60,800 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $433,825 | 25,900 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $832,054 | 27,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $214,970 | 7,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,811,099 | 152,588 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||